Hemostats Market - Global Industry Analysis

Hemostats Market, By Product Type (Gelatin-based Hemostats, Thrombin-based, Collagen-based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, and Combination Hemostats): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 08-Dec-2020 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-1555 Status : Published

The hemostats market is set for a rapid growth over the forecast period. In terms of revenue, the global hemostats market accounted for USD 2.65 Billion in 2019 and is expected to reach USD 3.95 Billion by 2026, growing at a CAGR of 6.4%.

Description

The hemostats market is set for a rapid growth over the forecast period. In terms of revenue, the global hemostats market accounted for USD 2.65 Billion in 2019 and is expected to reach USD 3.95 Billion by 2026, growing at a CAGR of 6.4%.

Global Hemostats Market: Overview

The hemostat is also known as arterial forceps or hemostatic clamp. It is a surgical tool that is used during major surgical procedures in order to control blood loss or halt bleeding during surgery. It is basically used in the early phases of surgery for an initial incision that closes blood vessels until ligation. Hemostats consist of a group of instruments that include pivot, tissue holders, needle holders, and various clamps. Reduce blood loss by hemostasis is the major challenge in any surgery. It can be achieved by various methods such as flowable and sealants, mechanical methods, active agents, thermal energy based devices, topical hemostatic agents, pharmaceutical agents, and thermal energy based devices. This procedure ensures strong adhesion of wound edges, rapid cessation of blood loss, tight sealing, prompt closure, reduced scarring, rapid healing, and reduced risk of infection.

Global Hemostats Market: Growth Factors

The hemostat clinical practice is growing very rapidly across the world thus anticipating boosting the global hemostats market growth. It offers lucrative growth opportunities for the market growth due to the presence of a pool of patients throughout the world. The affordable price of the tools expects to fuel the market growth. The surgical staple is the widely used tool to close the wounds. Topical hemostatic agents are broadly preferred as an alternative to standard suturing techniques in order to halt bleeding.

Global Hemostats Market: Segmentation

The global hemostats market is bifurcated on the basis of product type and region. The product type segment includes gelatin-based hemostats, thrombin-based, collagen-based hemostats, oxidized regenerated cellulose based hemostats, and combination hemostats. The regional breakdown of the hemostats market is given by North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Global Hemostats Market: Regional Analysis

North America is the leading consumer of the hemostats which is followed by Europe and Asia-Pacific region. Various strategies are adopted by the market players such as joint ventures, new product launches, agreements, partnerships, and collaborations in order to enhance the market revenue in the North America which contributes to the market growth. Increasing healthcare infrastructure coupled with rise in the number of surgeries is projected to propel the market in Europe. Asia-Pacific is the fastest growing region owing to increasing number of surgeries and change in regulatory policies encourages the market in the region. Other major factors propelling the global hemostats market growth are swift adoption of innovative products, early adoption of highly developed technologies, and improved healthcare facilities in the region.

Global Hemostats Market: Competitive Players

The key market players that are dominating the hemostats market include Anika Therapeutics, Inc., C.R. Bard, B. Braun Melsungen, Pfizer, 3-D Matrix, Ltd., Medtrade Products Ltd., Stryker, Baxter, Integra Lifesciences Corporation, Resorba Medical GmbH., and Vascular Solutions, Inc. Other influencing market players in the market are Gamma Therapeutics, Inc., Arch Therapeutics Inc., CSL Behring, Equimedical, B.V., Biom’Up SAS, Medline Industries, Inc., Hemostasis, LLC, CryoLife, Inc., Mallinckrodt Plc., Hemostasis, LLC, and Hemotec Medical GmbH.

Global Hemostats Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.2.Report Scope
  • Chapter 2.Research Methodology
    • 2.1.Research Methodology
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global Hemostats Market, 2016 – 2026 (USD Million)
    • 3.2.Global Hemostats Market: Snapshot
  • Chapter 4.Hemostats Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
      • 4.2.1.Driving Factor 1 Analysis
      • 4.2.2.Driving Factor 2 Analysis:
    • 4.3.Market Restraints
      • 4.3.1.Restraining Factor Analysis
    • 4.4.Market Opportunities
      • 4.4.1.Market Opportunity & Use-case Anaysis
      • 4.4.2.Use – Cases for Hemostats
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
      • 4.6.1.1.Impact on Product Development and Technology Adoption
      • 4.6.1.2.Gap Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global Hemostats Market Attractiveness, By Product Type
    • 5.2.Global Hemostats Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Strategic Developments
  • Chapter 7.Hemostats Market – Product Type Segment Analysis
    • 7.1.Global Hemostats Market Overview: by Product Type
      • 7.1.1.Global Hemostats Market Revenue Share, by Product Type, 2019 & 2026
    • 7.2.Global Hemostats Market Analysis/Overview – By Product Type
      • 7.2.1.Gelatin-based Hemostats – Overview/Analysis
      • 7.2.2.Thrombin-based Hemostats – Overview/Analysis
      • 7.2.3.Cullagen-based Hemostats – Overview/Analysis
      • 7.2.4.Oxidized Regenerated Cellulose Based Hemostats – Overview/Analysis
      • 7.2.5.Combination Hemostats – Overview/Analysis
    • 7.3.Gelatin-based Hemostats
      • 7.3.1.Global Hemostats Market for Gelatin-based Hemostats, Revenue (USD Million) 2016 - 2026
    • 7.4.Thrombin-based Hemostats
      • 7.4.1.Global Hemostats Market for Thrombin-based Hemostats, Revenue (USD Million) 2016 - 2026
    • 7.5.Cullagen-based Hemostats
      • 7.5.1.Global Hemostats Market for Cullagen-based Hemostats, Revenue (USD Million) 2016 - 2026
    • 7.6.Oxidized Regenerated Cellulose Based Hemostats
      • 7.6.1.Global Hemostats Market for Oxidized Regenerated Cellulose Based Hemostats, Revenue (USD Million) 2016 - 2026
    • 7.7.Combination Hemostats
      • 7.7.1.Global Hemostats Market for Combination Hemostats, Revenue (USD Million) 2016 - 2026
  • Chapter 8.Hemostats Market – Regional Analysis
    • 8.1.Global Hemostats Market: Regional Overview
      • 8.1.1.Global Hemostats Market Revenue Share, by Region, 2019 & 2026
      • 8.1.2.Global Hemostats Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 8.2.North America
      • 8.2.1.North America Hemostats Market Revenue, 2016 - 2026 (USD Million)
      • 8.2.2.North America Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 8.2.3.North America Hemostats Market Revenue, by Product Type, 2016 – 2026
      • 8.2.4. U.S.
      • 8.2.5.Canada
      • 8.2.6.Mexico
    • 8.3.Europe
      • 8.3.1.Europe Hemostats Market Revenue, 2016 - 2026 (USD Million)
      • 8.3.2.Europe Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 8.3.3.Europe Hemostats Market Revenue, by Product Type, 2016 – 2026
      • 8.3.4.Germany
      • 8.3.5.France
      • 8.3.6. U.K.
      • 8.3.7.Italy
      • 8.3.8.Spain
      • 8.3.9.Rest of Europe
    • 8.4.Asia Pacific
      • 8.4.1.Asia Pacific Hemostats Market Revenue, 2016 - 2026 (USD Million)
      • 8.4.2.Asia Pacific Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 8.4.3.Asia Pacific Hemostats Market Revenue, by Product Type, 2016 – 2026
      • 8.4.4.China
      • 8.4.5.Japan
      • 8.4.6.India
      • 8.4.7.South Korea
      • 8.4.8.South-East Asia
      • 8.4.9.Rest of Asia Pacific
    • 8.5.Latin America
      • 8.5.1.Latin America Hemostats Market Revenue, 2016 - 2026 (USD Million)
      • 8.5.2.Latin America Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 8.5.3.Latin America Hemostats Market Revenue, by Product Type, 2016 – 2026
      • 8.5.4.Brazil
      • 8.5.5.Rest of Latin America
    • 8.6.The Middle-East and Africa
      • 8.6.1.The Middle-East and Africa Hemostats Market Revenue, 2016 - 2026 (USD Million)
      • 8.6.2.The Middle-East and Africa Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 8.6.3.The Middle-East and Africa Hemostats Market Revenue, by Product Type, 2016 – 2026
      • 8.6.4.GCC Countries
      • 8.6.5.South Africa
      • 8.6.6.Rest of Middle-East Africa
  • Chapter 9.Company Profiles
    • 9.1.Anika Therapeutics Inc.
    • 9.2. C.R. Bard
    • 9.3.B. Braun Melsungen
    • 9.4.Pfizer
    • 9.5.3-D Matrix Ltd.
    • 9.6.Medtrade Products Ltd.
    • 9.7.Stryker
    • 9.8.Baxter
    • 9.9.Integra Lifesciences Corporation
    • 9.1.Resorba Medical GmbH.
    • 9.11.Vascular Sulutions Inc.
    • 9.12.Gamma Therapeutics Inc.
    • 9.13.Arch Therapeutics Inc.
    • 9.14.CSL Behring
    • 9.15.Equimedical B.V.
    • 9.16.Biom’Up SAS
    • 9.17.Medline Industries Inc.
    • 9.18.Hemostasis LLC
    • 9.19.CryoLife Inc.
    • 9.2.Mallinckrodt Plc.
    • 9.21.Hemostasis LLC
    • 9.22.Hemotec Medical GmbH.

List of Figures  

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Hemostats Market Revenue, 2016 - 2026 (USD Million)
FIG. 5 Porter’s Five Forces Analysis for Global Hemostats Market
FIG. 6 Global Hemostats Market Attractiveness, By Product Type
FIG. 7 Global Hemostats Market Attractiveness, By Region
FIG. 8 Global Hemostats Market Revenue Share, by Product Type, 2019 & 2026
FIG. 9 Global Hemostats Market for Gelatin-based Hemostats, Revenue (USD Million) 2016 - 2026
FIG. 10 Global Hemostats Market for Thrombin-based Hemostats, Revenue (USD Million) 2016 - 2026
FIG. 11 Global Hemostats Market for Collagen-based Hemostats, Revenue (USD Million) 2016 - 2026
FIG. 12 Global Hemostats Market for Oxidized Regenerated Cellulose Based Hemostats, Revenue (USD Million) 2016 - 2026
FIG. 13 Global Hemostats Market for Combination Hemostats, Revenue (USD Million) 2016 - 2026
FIG. 14 Global Hemostats Market Revenue Share, by Region, 2019 & 2026
FIG. 15 North America Hemostats Market Revenue, 2016 - 2026 (USD Million)
FIG. 16 Europe Hemostats Market Revenue, 2016 - 2026 (USD Million)
FIG. 17 Asia Pacific Hemostats Market Revenue, 2016 - 2026 (USD Million)
FIG. 18 Latin America Hemostats Market Revenue, 2016 - 2026 (USD Million)
FIG. 19 The Middle-East and Africa Hemostats Market Revenue, 2016 - 2026 (USD Million)
 


List of Tables 

TABLE 1 Global Hemostats Market: Snapshot
TABLE 2 Drivers of the Hemostats Market: Impact Analysis
TABLE 3 Restraints for the Hemostats Market: Impact Analysis
TABLE 4 Global Hemostats Market Revenue, by Region, 2016 – 2026 (USD Million)
TABLE 5 North America Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 6 North America Hemostats Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 7 Europe Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 8 Europe Hemostats Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 9 Asia Pacific Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 10 Asia Pacific Hemostats Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 11 Latin America Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 12 Latin America Hemostats Market Revenue, by Product Type, 2016 – 2026 (USD Million)
TABLE 13 The Middle-East and Africa Hemostats Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 14 The Middle-East and Africa Hemostats Market Revenue, by Product Type, 2016 – 2026 (USD Million)
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed